Tag: vagus nerve stimulation

First commercial Vivistim patient set to begin paired vagus nerve stimulation...

MicroTransponder recently announced the first commercial use of its Vivistim paired vagus nerve stimulation (VNS) system for improved upper-limb function post-stroke. The company said...

Dolphin vagal nerve stimulator gains Health Canada nod for ‘long-haul’ COVID-19...

Health Canada recently authorised the Dolphin vagal nerve stimulator to treat symptoms in patients with COVID-19 ‘long-haul’ symptoms (long haulers). Long haulers experience a wide variety of aftereffects...

Dolphin vagus nerve stimulation receives Health Canada approval as COVID-19 treatment

Center for Pain and Stress Research today announced that its Dolphin vagus nerve stimulation (VNS) device has received breakthrough approval from Health Canada—making it...

Feinstein Institutes scientists develop “first-of-its-kind” wireless neuromodulation device for research

Engineers and researchers in the Institute of Bioelectronic Medicine at the Feinstein Institutes for Medical Research have developed a novel, fully implantable, wireless bidirectional vagus nerve stimulation (VNS)...

MicroTransponder receives best new product award for Vivistim system

MicroTransponder today announced that its Vivistim paired vagus nerve stimulation (VNS) system has won the Neurotech Reports Gold Electrode Award for best new product. This announcement...
vivistim system

MicroTransponder gains FDA approval for first-of-its-kind VNS system to improve stroke...

MicroTransponder has announced US Food and Drug Administration (FDA) premarket approval of the Vivistim paired vagus nerve stimulation (VNS) system, which—according to a company...
LivaNova RECOVER design published

New study shows significant positive impact of vagus nerve stimulation therapy...

Adding vagus nerve stimulation (VNS) therapy to treatment as usual (TAU) has been demonstrated to improve outcomes in patients with treatment-resistant bipolar depression (TRBD)....
Peter Staats COVID-19 nVNS

Non-invasive vagus nerve stimulation may provide clinical benefit to patients with...

An article accepted into the journal Neuromodulation has concluded that, based on two case reports, non-invasive vagus nerve stimulation (nVNS) might provide clinical benefits...

Cervical non-invasive vagus nerve stimulation effectively relieves pain in migraine sufferers

A recent meta-analysis demonstrated that cervical non-invasive vagus nerve stimulation (nVNS) is a safe and effective method for acute pain relief in migraine and...
LivaNova RECOVER design published

LivaNova collaborates with Verily to fuel research into vagus nerve stimulation...

LivaNova has announced a research collaboration with Verily, an Alphabet company, to capture measures of depression within its RECOVER clinical study, which is evaluating...

News from NANS: First long-term vagus nerve stimulation implant in mice

Data showing the effective use of a long-term vagus nerve implant in mice have been presented at the North American Neuromodulation Society’s (NANS) annual...
RECOVER

LivaNova enrols first patient in RECOVER clinical study

LivaNova has announced the first patient enrolled in their RECOVER trial, a prospective, multi-centre, randomised controlled blinded trial demonstrating the safety and effectiveness of...
LivaNova RECOVER design published

CMS trial clearance for LivaNova’s vagus nerve stimulation therapy for treatment-resistant...

LivaNova has recognised that the US Centers for Medicare & Medicaid Services (CMS) finalised its National Coverage Determination (NCD) for the LivaNova vagus nerve...

FDA approves SenTiva device for treatment of epilepsy

LivaNova has received US Food and Drug Administration (FDA) approvals for its latest Vagus Nerve Stimulation (VNS) Therapy System, which consists of the SenTiva implantable...

LivaNova’s VNS Therapy receives FDA approval for expanded MRI labelling

  LivaNova’s latest vagus nerve stimulation (VNS Therapy) system has received US Food and Drug Administration (FDA) approval for expanded magnetic resonance imaging labelling. According...